US FDA’s Eflornithine Review Is Showcase For Deep Oncology Team

The advisory committee review of US WorldMeds’ eflornithine for neuroblastoma was remarkable for the unusual nature of the efficacy data to support the NDA – and also for who spoke on behalf of the agency and how effectively they walked the panel through a complex set of issues.

locker room shirts
FDA has many oncology team members ready to suit up for advisory committees. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers